A Randomised, Multi-centre, Double-blind, Active-controlled, Parallel Group Study to Assess the Efficacy and Safety of Modified Release Prednisone (Lodotra®) Compared to Immediate Release Prednisone (Prednisone IR) in Subjects Suffering From Polymyalgia Rheumatica (PMR).

Trial Profile

A Randomised, Multi-centre, Double-blind, Active-controlled, Parallel Group Study to Assess the Efficacy and Safety of Modified Release Prednisone (Lodotra®) Compared to Immediate Release Prednisone (Prednisone IR) in Subjects Suffering From Polymyalgia Rheumatica (PMR).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 11 Nov 2015

At a glance

  • Drugs Prednisone (Primary)
  • Indications Polymyalgia rheumatica
  • Focus Registrational; Therapeutic Use
  • Sponsors Mundipharma Research
  • Most Recent Events

    • 01 Apr 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 20 Feb 2014 Status changed from recruiting to active, no longer recruiting reported by ClinicalTrials.gov record.
    • 26 Mar 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01821040).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top